FDA Approves Zilbrysq for Myasthenia Gravis : comparemela.co

Zilbrysq (zilucoplan) is the first self-administered treatment for myasthenia gravis. Rapid symptom improvements were observed in clinical trials.

Related Keywords

Stanford , California , United States , University Of North Carolina , North Carolina , Palo Alto , Winston Salem , Rachana Gandhi Mehta , Charles Cho , Mjamesf Howard , Atrium Health Wake Forest Baptist , Myasthenia Gravis Foundation Of America , Stanford Neuroscience Health Center , Drug Administration , Drug Offers Freedom , North Carolina Chapel Hill School , Fatigue Common People With , Myasthenia Gravis Foundation , Offers Improvements , Lancet Neurology , Could Improve Management , Medication Options Needed , Side Effects ,